Control of Resting Ca2+ Concentration in Skeletal Muscle

Control of Resting Ca2+ Concentration in Skeletal Muscle

Chapter 56 Control of Resting Ca21 Concentration in Skeletal Muscle Jose R. Lopez and Paul D. Allen Department of Anesthesia, Perioperative and Pain ...

291KB Sizes 1 Downloads 69 Views

Chapter 56

Control of Resting Ca21 Concentration in Skeletal Muscle Jose R. Lopez and Paul D. Allen Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

INTRODUCTION Ca21 is a critical signaling molecule within cells (1). Many cellular functions are directly or indirectly regulated by intracellular calcium concentration ([Ca21]i), and because cells extract specific information from changes in [Ca21]i over time, in space and in amplitude all three parameters must be very tightly regulated. Under resting conditions, skeletal muscle cells maintain [Ca21]i in a narrow range near 100 nM. This low cytosolic concentration has been described in both frog (2) and mammalian skeletal muscle (3 5). Because the gradient between resting myoplasmic free calcium and the extracellular space and internal stores is about 10,000-fold, to constantly keep [Ca21]i in the nM concentration range muscle cells use a complex dynamic equilibrium of Ca21 fluxes among pumps (plasma membrane Ca21 ATPase, and sarcoplasmic reticulum Ca21 ATPase) and an exchanger (Na1/Ca21exchanger) opposed by sarcoplasmic reticulum (SR) leak channels (ryanodine-insensitive “Ca21 leak”) as well as basal sarcolemmal Ca21 influx (6) which tunes myoplasmic Ca21 homeostasis at rest (see Figure 56.1).

MECHANISMS FOR Ca21 REMOVAL FROM THE MYOPLASM OF MUSCLE CELLS Sarcolemmal Outward Ca21 Transport Mechanisms It is generally accepted that the control of resting [Ca21]i in mammalian muscle cells is via plasmalemmal Ca21 extrusion via the sodium calcium exchanger (NCX) and the calmodulin-regulated plasma membrane Ca-ATPase (PMCA).

Sodium Calcium Exchanger (NCX) The NCX is an electrogenic (3Na1/1Ca21) and reversible counter transport system with a well-established role in

Muscle. DOI: http://dx.doi.org/10.1016/B978-0-12-381510-1.00056-9 © 2012 Elsevier Inc. All rights reserved.

Ca21 homeostasis in a variety of cells (7), including amphibian and mammalian skeletal muscle and mammalian myotubes (8 10). Three mammalian isoforms of the NCX protein that are products of three different genes have been cloned (11 13) and appear to have very similar properties (14). In its forward mode, NCX can operate as a high capacity and low affinity system for Ca21 transport, extruding Ca21 against its transmembrane electrochemical gradient, making use of the Na1 electrochemical gradient (7). Given the right balance between the respective electrochemical gradients, the NCX can also operate in the reverse mode, transporting Ca21 into cells and Na1 out (7). Although both NCX1 and NCX3 isoforms have been found in the transverse tubule (T-tubule) and the sarcolemma (10,15) in mammalian skeletal muscle, the physiological role for NCX in muscle has not yet been defined. Muscle fibers from amphibian skeletal muscle (8,16) and human myotubes (10) have been shown to exhibit Na1dependent Ca21 efflux (forward and reverse mode). Recently we have found that NCX in its reverse mode may play an important role in the regulation of resting [Ca21]i in muscle fibers which express RyR1s with mutations associated with malignant hyperthermia. A possible explanation for this is the high resting [Na1]i (15 mM) that we have found in these cells. In practical terms the elevation of [Ca21]i during contraction activates the NXC forward mode, and an elevation of [Na1]i above normal resting values will result in enhanced Ca21 influx via the NCX-reverse mode (Lopez et al., unpublished results).

Plasma Membrane Ca21-ATPase (PMCA) Plasma membrane calcium pumps, also known as the plasma membrane Ca21-ATPase or PMCA, are responsible for the expulsion of Ca21 from the cytosol of all eukaryotic cells. Together with NCX, they are the major plasma membrane transport system responsible for the long-term regulation of the resting [Ca21]i. Like the

801

802

PART | III

jSR Transverse tubule

Skeletal Muscle

nSR

SOC TRP Triadin Ora1

Ca2+

DHPR NCX

RyR1 SERCA1

PMCA

Junctin

ADP3− Matrix − space Inner membrane Pi Outer membrane

ADP4− ANT

Inter-membrane space

CASQ1 polymer

F1

CASQ1 monomer

Cytosol

FKBP12

+

FIGURE 56.1 Cartoon model of skeletal muscle showing all of the proposed involved proteins in the macromolecular CRU complex that play a significant role in controlling Ca21 homeostasis at rest.

Ca21 pump of the sarcoplasmic/endoplasmic reticulum (SERCA), which pumps Ca21 from the cytosol into the SR, PMCA belong to the family of P-type, named so because these calcium-transport proteins undergo autophosphorylation in which the γ-phosphate of ATP is transferred to a highly conserved aspartyl residue in the cytoplasmic portion of the protein (17). Mammalian PMCA are encoded by four separate genes and additional isoform variants are generated via alternative RNA splicing of the primary gene transcripts (18,19). The expression of different PMCA isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. Different PMCA isoforms have different basal activities, affinities for calmodulin and rates of activation and

inactivation (20), suggesting they may have different physiological roles. The PMCA has low capacity but high affinity for Ca21 transport with a 1:1 Ca21/ATP stoichiometry. Work on purified protein reconstituted in liposomes had suggested electroneutrality (21) while other experiments have suggested that it is a partially electrogenic 1:1 Ca21:H1 transport process (22). The activity of the pump in native membranes has been found to be insensitive to the variation of the membrane potential, strongly supporting an electroneutral H1/Ca21 reaction (23). Under conditions found in the cell, the Kd of the pump for Ca21 is in the 200 500 nM range. Although the Ca21 affinity of the PMCA pump is lower than that of SERCA, it is high enough to enable it to operate with reasonable efficiency at Ca21 concentrations such as those prevailing in the

Chapter | 56

Control of Resting Ca21 Concentration in Skeletal Muscle

myoplasm at rest. Accordingly, the PMCA has been conventionally defined as the fine tuner of cytosolic [Ca21]. However the physiological contribution of PMCA to the intracellular Ca21 homeostasis in skeletal muscle still is not fully defined. One significant reason for this is that there are no specific pharmacological inhibitors for any of the PMCA isoforms or splice variants and until muscle-specific genetic manipulation, i.e., selective “knock out or knock down” or overexpression of specific PMCA isoforms is done in skeletal muscle its regulation of contraction/relaxation in adult animals will be unknown.

SR Ca

21

Reuptake: the SERCA Pump

It is well established that active transport is required to import Ca21 into the lumen of SR after muscle activation (for review see 24). The SR of skeletal muscle is an extensively developed network of tubules and cisternae that is arranged in a precise geometric relationship to the contractile elements (25) and represents the primary calcium-storage organelle in striated muscle. The 100 kDa ATP-dependent Ca21 pump (SERCA) is an intrinsic component of the SR membrane in muscle cells, which makes up 50 80% of the total protein of endoplasmic reticulum (26). SERCA-mediated SR calcium reuptake controls the rate of muscle relaxation in skeletal muscle and is responsible for maintaining a 10,000-fold calcium gradient across the SR membrane. Like the PMCA, SERCA is a member of the family of P-type Ca21-ATPases (17). The ATP-dependent Ca21 pump is evenly distributed throughout the free SR and catalyzes the electrogenic transport of 2 Ca21 coupled to the hydrolysis of 1 mol of ATP, against a large electrochemical gradient of Ca21. Unlike the PMCA, SERCA is relatively insensitive to calmodulin (27,28). Brody’s disease is a rare recessive genetic disease associated with mutation in SERCA characterized by impaired relaxation, painless cramps, and stiffness following exercise (29). Three mutations in the SERCA1 gene have been identified in two affected families (30). These patients can still relax their muscles, although at a significantly reduced rate. This suggests that some compensation by ectopic expression of other SERCA isoforms (SERCA2 or SERCA3), and/or that Ca21 removal from the cytosol by the PMCA pump and/or the Na1/Ca21 exchanger could limit the defect in the Ca21-clearing activity of the SR. Although it has been generally thought that the only function of SERCA1 is the reuptake of Ca21 after muscle contraction and that the overall control of resting cytosolic [Ca21] is via the pumps and exchangers at the sarcolemma, recent studies suggest that this is not the case. Goonasakera et al. have shown that by overexpressing SERCA1 in skeletal muscle of mice with three severe

803

myopathic conditions that the pathologic changes associated with these myopathies could be abrogated (31). Because some, and it is likely all, of these conditions are associated with increased resting [Ca21]i these data suggest that the control of resting [Ca21]i is not limited to the sarcolemma but may also be mediated by SR Ca21 uptake.

MECHANISMS FOR Ca21 ENTRY INTO THE MYOPLASM IN SKELETAL MUSCLE Sarcolemmal Ca21 Entry Mechanisms It was established decades ago that excitation contraction (EC) coupling relies on the depolarization-dependent release of stored calcium in the SR for skeletal muscle contraction (32,33). More recently, growing evidence suggests that alternative calcium signaling pathways rely on sarcolemmal calcium entry (34 36). Two forms of Ca21 entry have been characterized in skeletal muscle fibers: excitation-coupled calcium entry (ECCE), which is activated in muscle cells during prolonged membrane depolarization and is independent of the filling state, and store-operated calcium entry (SOCE) (37), which occurs in response to depletion of the internal stores (for reviews see 38, 39).

Excitation-Coupled Ca21 Entry (ECCE) It has been reported that the interaction between the DHPR and RYR1 during activation promotes entry of extracellular Ca21 into the myoplasm in skeletal myotubes (5,37) and adult muscle fibers (40). This form of Ca21 entry is termed excitation-coupled Ca21 entry (ECCE). Although the molecular identity of the ECCE pore remains undefined, some authors have suggested it is the L-type calcium channel (41 43). ECCE requires the expression of both the DHPR and RYR1, as it is absent in both dysgenic (CaV1.1-null) and dyspedic (RYR1-null) myotubes (37). Interestingly, ECCE is enhanced by conformational changes in RYR1 such as those caused by ryanodine, certain cysteine mutations and mutations that are associated with malignant hyperthermia (5,40,44). Pharmacologically, ECCE can be blocked by 2-aminoethyl diphenylborate (2-APB), SKF 96356, La31, Gd31, and dantrolene (37,43,45). ECCE is independent of stores and can occur both without any store depletion (36,37,40,45) and in cells in which stores are fully depleted (37,46). Thus, it appears that ECCE may be important in normal skeletal muscle in helping to maintain force generation during tetanic stimulation, and accentuated ECCE may contribute to the pathophysiological increase in myoplasmic Ca21 in malignant hyperthermia.

804

Store-Operated Ca21 Entry (SOCE) Capacitative Ca21 entry, or store-operated Ca21 entry (SOCE), was first described and characterized in nonexcitable cells, where it constitutes a major pathway for Ca21 influx (38). The electrical manifestation of this Ca21 entry in the continuous presence of extracellular Ca21 is a Ca21 current, Icrac, whose mechanism has recently been described as an interaction between Orai1 in the plasmalemma and STIM1 in the ER (47). Activation of SOCE is not restricted to nonexcitable cells, but is also observed in excitable cells including neurons, cardiac myocytes, and smooth muscle cells (48). This mode of Ca21 entry has also been described in myotubes and in adult skeletal muscle fibers, where release from SR Ca21 stores is operated by RyRs (6,35,49 51). The physiological role of SOCE in skeletal muscle is not well understood, but it is likely to be important for sustaining calcium stores to prevent muscle weakness and contribute calcium needed to modulate muscle-specific gene expression (52). Although other mechanisms have been proposed as the basis of SOCE in skeletal muscle, such as activation of SOCE channels by IP3 receptors (50) or RyR1 as the SR Ca21 sensor (53,54) and via TRPC proteins as the SOCE channel (53,55,56), it has recently been shown that SOCE in muscle is the result of highly Ca21-selective CRAC channel activation (57,58), resulting from store depletion causing STIM1 aggregation and reorganization in diverse regions of the SR that interact and activate Ca21 entry via Orai1 channels sarcolemma (57).

Transient Receptor Potential Channels (TRPs) TRP channels show a great diversity in activation and ion selectivity. Transcripts for TRPC subfamily members 1, 2, 3, 4, and 6 have been found in skeletal muscle and confirmed by Western blot. Immunohistochemical staining shows the presence of TRPC1, 3, 4, and 6 in the sarcolemma (55,59 61), however in other studies TRPC1, 4, and 6 showed a sarcolemmal localization while TRPC3 was preferentially found in the intracellular compartment, both in isolated fibers (61) and muscle cross-sections (59) but comparisons of TRPC channel expression between different skeletal muscles revealed significant variations (60). TRPC1, 2, 3, 4, and 6 mediate the transmembrane flux of cations down their electrochemical gradients, and because they are not selective for Ca21 their activation can increase both the intracellular Ca21 and Na1 concentrations. The mechanism by which TRPC channels are activated is unknown but possible mechanisms include (i) hydrolysis of phosphatidylinositol bis-phosphate (PIP2); (ii) diacylglycerol (DAG); (iii) by inositol (1,4,5)

PART | III

Skeletal Muscle

tris-phosphate (IP3); (iv) direct activation by changes in temperature, mechanical stimuli or inorganic ions (Ca21 and Mg21) (62). Co-immunoprecipitation and co-localization experiments suggested an association of TRPC1, TRPC4, and α-syntrophin in cultured myotubes (61,63). These data suggest that TRPC1 is associated via syntrophin to the complex of dystrophin-associated glycoproteins (DAG) and that TRPC1 may form a Ca21 channel or at least contributes to as a subunit of a Ca21 influx channel. In addition, connecting to the DAG complex, TRPC1 co-localizes with the scaffolding protein Homer 1 in skeletal muscle fibers (63). Knockdown of TRPC3 by small interference RNAs did not impair muscle differentiation and neither SOCE nor ECCE were impaired; however the association of TRPC3 with the calcineurinNFAT (nuclear factor of activated T cells) signal transduction pathway is thought to couple extracellular Ca21 influx with regulation of gene expression (64).

Resting Ca21 Entry and Resting [Ca21]i In quiescent muscle cells resting [Ca21]i is maintained, in part, by a continuous Ca21 influx that is not mediated by ECCE or SOCE. This resting Ca21 entry (RCaE) appears to play an important role in preserving the resting [Ca21]i in skeletal muscle (6). The cation channels responsible for RCaE, most probably TRPCs, show a variable Ca21/ Na1 ratio (65). Recent work demonstrated that RCaE could be blocked either by the Icrac blocker BTP2 or overexpression of a dominant negative form of Orai1 (E190Q) with a result being a reduction in resting [Ca21]i (6). In addition, we have recently found that Gd31 and GsMTx-4 (Chilean Rose Tarantula) can also block RCaE in muscle cells, and lower resting [Ca21]i and [Na1]i (Eltit et al., unpublished results). Together these data suggest a possible participation of both TRPCs and Orai in this novel Ca21 entry pathway. Additional investigation is required to completely identify the mechanisms that may be involved in the regulation of resting Ca21 entry in skeletal muscle.

SR Ca21 Leak A significant part of the Ca21 leak pathway from the SR into the cytoplasm arises from a ryanodine-insensitive constitutively open (POB1) low conductance conformation of RyR1 (6,66). Bastadin 5, a brominated macrocyclic derivative of dityrosine isolated from the marine sponge Iathella basta (67), modulates RyR1 gating behavior and can be used as a pharmacological tool to convert RyR1 from its leak conformation into a gating conformation (67). It is well known that the DHPR and the RyR1 engage in bidirectional signaling (68) and that physical coupling between them is essential for skeletal

Chapter | 56

Control of Resting Ca21 Concentration in Skeletal Muscle

excitation contraction coupling. Freeze-fracture images have shown that DHPRs are clustered in groups of four particles (tetrads), which due to steric hindrance are associated with alternate RyR1s in each Ca21 release unit (CRU). Thus alternate RyR1 channels are not physically coupled with DHPRs and the function of the uncoupled RyR1 population is unknown (69 71). Recently, Eltit and colleagues have identified a previously undiscovered orthograde signal from the DHPR to RyR1 that appears to dictate the ratio of actively gating RyR1 channels vs. those in the leak conformation (72). They speculate that since the RyR1 population not coupled to DHPRs in muscle should have a higher propensity to be in the leak conformation, this may be determinant in maintaining normal intracellular Ca21 homeostasis and is needed to keep myoplasmic [Ca21] and the SR Ca21 content in the physiological range (Figure 56.2).

METHODS FOR MEASUREMENTS RESTING [Ca21]I IN MUSCLE CELLS Measuring resting [Ca21]i in skeletal muscle has become an important issue for muscle physiologists. Two main approaches have been used for the determination of resting [Ca21]i in muscle: the introduction of indicators into muscle cells, by various means, which give luminescence, absorbance, or fluorescence signals that are proportional to the [Ca21]i and electrophysiologically using Ca21selective microelectrodes.

Ca2+ Ca2+ Ca2+

~2 mM

Ca2+

Ca2+ Ca2+

Ca2+

Ca2+

Ca2+ SR

~1 mM

Normal Ca2+ stores

~120 nM

805

Optical Indicators Three major classes of indicators have been used: (i) bioluminescent calcium-activated photoproteins; (ii) metalochromic indicators; and (iii) tetracarboxylate Ca21 chelator dyes. The first two are mentioned largely for historical interest.

Photoproteins Aequorin (73) is the best known of the two photoproteins that have been used as intracellular Ca21 indicators and has to be either microinjected into the cell or loaded when the cell membrane is partially permeabilized and then allowed to reseal. Measurements of resting [Ca21]i with aequorin are problematic both because its signal is very small at calcium concentrations that resemble the normal myoplasmic resting free calcium in muscle fibers determined by other methods, calibration of the signal into absolute [Ca21] is not easy, because the signal is influenced by a variety of experimental variable (ionic strength, temperature, [Mg21] and its emission proportional roughly to the [Ca21] to the power 2.5 (74), and because it has a luminescence signal that is independent of [Ca21] which has been reported at very low [Ca21] (74). Resting [Ca21]i values in the range of 39 80 nM have been reported in skeletal muscle microinjected with aequorin (75,76).

Metalochromic Dyes Metallochromic dyes change color on binding Ca21 and several different metallochromic dyes have been used in living muscle cells (77 81) as intracellular Ca21 indicators, however it was found that the properties of these dyes made them unsuitable and no one has used them to determine resting [Ca21]i in muscle cells. Three important limitations of metallochromic Ca21 indicators are: (1); that a major fraction of the dye molecules are bound to both soluble and fixed proteins in the muscle cell, making them inaccessible to sense Ca21 ionic activity in the resting state (79,81); (2) it has been estimated that twothirds of the dye is not freely available in the cytoplasm (79); and (3) sulfhydryl groups reduce metallochromic Ca21 indicators to form azo anion radicals that inhibit SERCA function (82).

Ca2+ Orai1/Stim1

TRPC

RyR1 Gating state

NCX/PMCA

RyR1 Leak state DHPR

SERCA1

FIGURE 56.2 Cartoon showing DHPR control of RyR1 “leaks” and mechanisms for Ca21 entry into and extrusion from the cytoplasm.

Tetracarboxylate Fluorescent Ca21 Chelator Dyes Most currently used fluorescent Ca21 indicators (highaffinity or low-affinity) are members of a family of tetracarboxylate derivatives of BAPTA (Fura-2, Indo-1, Fluo-3, Fluo-4, Rhod-2, Calcium Green, etc.), which for the most part have a high selectivity for calcium over

806

Mg21 and monovalent ions (83 85). One of the most attractive features of these Ca21 indicators is the ease with which they can be introduced into the muscle cells. Although as salts they are highly charged and alone cannot diffuse across the plasma membrane, in their acetomethyl ester (AM) salt form they become lipid-soluble and can penetrate the plasma membrane where the ester group is hydrolyzed by cytoplasmic esterases and the charged form of the tetracarboxylate derivative is trapped in the cytoplasm. Several studies have been conducted in diverse non-diseased muscle cells using these indicators to measure resting [Ca21]i (86 91). Unfortunately, a number of problems must be considered when tetracarboxylate indicators are used for the determination of resting [Ca21]i in muscle cells. (i) As BAPTA derivatives all have a chelator effect on Ca21 they reduce [Ca21]i. Thus in most cases the [Ca21]i that have been reported in muscle cells using this method have been significantly lower (range 20 80 nM) compared with those reported using Ca21 selective microelectrodes. (ii) The esterases capable of hydrolyzing the AM esters of these indicators are not located exclusively in the cytoplasm. They have been found in some cellular organelles such as SR and mitochondria, which can allow the indicator to be accumulated internally (92 94). (iii) Incomplete hydrolysis of the ester may occur in the interior of the muscle cell and different hydrolysis sub-products are generated whose properties are unknown (93). (iv) These indicators can leak out the cell in their unesterified or free acid form using an undefined active transport system, which is highly temperature-dependent (84,95,96). The leakage can be slowed by reducing the temperature or by treatment with probenecid. Unfortunately these interventions can also modify [Ca21]i. (v) All BAPTA-derivative fluorescent Ca21 indicators are subject to photobleaching and the product of the photobleaching is both fluorescent and relatively insensitive to Ca21(97). (vi) The fluorescence spectra or the calcium binding properties of these fluorescent Ca21 indicators are sufficiently altered in an intracellular environment to make the calibration curves done in aqueous buffers inappropriate (86,87,98,99). As an example, one indicator’s calculated Kd was smaller in aqueous solution alone than when it was measured with a myoplasmic protein, like aldolase, added to the buffer solution (100).

Ca21-Selective Microelectrodes The basis for this technique is the use of a Ca21 selective membrane (ligand) that separates two aqueous solutions containing Ca21 and the readout is the electrical potential difference established between the solutions. In practice, the membrane in the Ca21-selective microelectrodes is a short column of Ca21-selective neutral carrier ligand,

PART | III

Skeletal Muscle

which separates two different solutions, a microelectrode filling solution (usually pCa7) and the solution outside the microelectrode tip. Neutral carriers are uncharged organic molecules that bind specific ions, generating an electrical potential (100,101). Current available neutral ligand sensors, ETH-1001 (102) and ETH-129 (103), have an adequate selectivity against Na1, K1, and H1 and have negligible interference from Mg2. Ca21-selective microelectrodes made with these ligands can give a well-calibrated measurement of [Ca21]i, over the full range of [Ca21]i of biological interest from pCa3 to below pCa8 in single muscle cells. Typically their response is Nernstian (29.5 mV/pCa unit at room temperature) from pCa3 7 and the signal down to pCa8 is useable. When Ca21-selective microelectrodes made with either ETH-1001 (103) or ETH-127 (104) have been used to measure [Ca21]i in skeletal muscle, the majority of values reported in normal muscle have been in the vicinity of 100 nM (2,4,5,6,85,105,106). However, Ca21-selective microelectrodes have some drawbacks. The most important is that they respond very slowly to changes in [Ca21]i due to the high electrical resistance of the neutral ligand. For measurements of resting [Ca21]i in quiescent muscle cells (steady-state), this slow response is not a limiting factor but it does make their use inappropriate to track rapid changes [Ca21]i, such as those observed during muscle activation. Another potential disadvantage of Ca21-selective microelectrodes lies in that they sample [Ca21]i from just one point which could under certain circumstances not represent the [Ca21]i in all parts of the cell. However, in skeletal muscle there is no evidence of intracellular Ca21 gradients at rest (107), so this problem is moot. Lastly this method is very demanding technically and requires special skills, and because with repeated use their sensitivity to Ca21 may change in the course of the experiments, a calibration curve must be carried out both before and after intracellular measurements. It has been suggested by some investigators that Ca21 measurements carried out using Ca21 selective microelectrodes do not represent the true intracellular Ca21 concentration due to membrane damage caused by electrode impalement (90,91). In general any muscle cell damage due to microelectrode impalements appears to be associated with either the use of microelectrodes with a tip size greater than 1 μm or inadequate care during cell impalement. In this regard we have monitored microelectrode impalements in muscle cells previously loaded with Indo1 AM or Fluo-4 AM and we have not observed any detectable increase in the fluorescence signal during or after the impalement was carried out, ruling out any potential membrane damage and leakage of Ca21 around the microelectrode (Yang et al., unpublished observations). In addition, measurements of [Ca21]i in muscle

Chapter | 56

Control of Resting Ca21 Concentration in Skeletal Muscle

cells done after impalement in high extracellular [Ca21] solutions (12.5 mM) (105), are not different than those obtained when the impalement is done in normal Ringer solution (2 mM).

SUMMARY In summary, maintenance of the gradient between resting [Ca21]i inside muscle cells and the extracellular space and internal stores requires a complex dynamic equilibrium of Ca21 fluxes among pumps (PMCA, and SERCA) and an exchanger (NCX) which is opposed by sarcoplasmic reticulum (SR) leak channels (ryanodine insensitive “Ca21 leak”) as well as basal sarcolemmal Ca21 influx. Against what has been commonly thought and has been stated as the boundary theorem (108) which supposes that [Ca21]i is controlled solely by the sarcolemmal Ca21 fluxes, it is clear from recent data that this is not the case. Although sarcolemmal Ca21 fluxes do play an important role, the contribution of Ca21 fluxes in and out of the internal store must be considered in the overall equation.

ACKNOWLEDGMENTS The authors wish to express their thanks to Dr Jose M. Eltit for reading the manuscript and Francisco Altamirano for his help in preparation. Funding for the unpublished data was supported by grants to P.D.A. from NIH/NIAMS (AR43140, AR052354, and AR055104).

REFERENCES 1. Brini M, Manni S, Carafoli E. A study of the activity of the plasma membrane Na/Ca exchanger in the cellular environment. Ann NY Acad Sci 2002;976:376 81. 2. Lopez JR, Alamo L, Caputo C, DiPolo R, Vergara S. Determination of ionic calcium in frog skeletal muscle fibers. Biophys J 1983;43:1 4. 3. Lopez JR, Briceno LE, Sanchez V, Horvart D. Myoplasmic (Ca21) in Duchenne muscular dystrophy patients. Acta Cient Venez 1987;38:503 4. 4. Lopez JR, Allen PD, Alamo L, Jones D, Sreter FA. Myoplasmic free [Ca21] during a malignant hyperthermia episode in swine. Muscle Nerve 1988;11:82 8. 5. Yang T, Esteve E, Pessah IN, Molinski TF, Allen PD, Lopez JR. Elevated resting [Ca(21)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol 2007;292:C1591 8. 6. Eltit JM, Yang T, Li H, Molinski TF, Pessah IN, Allen PD, et al. RyR1-mediated Ca21 leak and Ca21 entry determine resting intracellular Ca21 in skeletal myotubes. J Biol Chem 2010;285:13781 7. 7. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 1999;79:763 854.

807

8. Cifuentes F, Vergara J, Hidalgo C. Sodium/calcium exchange in amphibian skeletal muscle fibers and isolated transverse tubules. Am J Physiol Cell Physiol 2000;279:C89 97. 9. Deval E, Levitsky DO, Constantin B, Raymond G, Cognard C. Expression of the sodium/calcium exchanger in mammalian skeletal muscle cells in primary culture. Exp Cell Res 2000;255:291 302. 10. Deval E, Levitsky DO, Marchand E, Cantereau A, Raymond G, Cognard C. Na(1)/Ca(21) exchange in human myotubes: intracellular calcium rises in response to external sodium depletion are enhanced in DMD. Neuromuscul Disord 2002;12:665 73. 11. Li Z, Matsuoka S, Hryshko LV, Nicoll DA, Bersohn MM, Burke EP, et al. Cloning of the NCX2 isoform of the plasma membrane Na(1)-Ca21 exchanger. J Biol Chem 1994;269:17434 9. 12. Nicoll DA, Longoni S, Philipson KD. Molecular cloning and functional expression of the cardiac sarcolemmal Na(1)-Ca21 exchanger. Science 1990;250:562 5. 13. Nicoll DA, Quednau BD, Qui Z, Xia YR, Lusis AJ, Philipson KD. Cloning of a third mammalian Na1-Ca21 exchanger, NCX3. J Biol Chem 1996;271:24914 21. 14. Linck B, Qiu Z, He Z, Tong Q, Hilgemann DW, Philipson KD. Functional comparison of the three isoforms of the Na1/Ca21 exchanger (NCX1, NCX2, NCX3). Am J Physiol 1998;274: C415 23. 15. Sacchetto R, Margreth A, Pelosi M, Carafoli E. Colocalization of the dihydropyridine receptor, the plasma-membrane calcium ATPase isoform 1 and the sodium/calcium exchanger to the junctional-membrane domain of transverse tubules of rabbit skeletal muscle. Eur J Biochem 1996;237:483 8. 16. Caputo C, Bolanos P. Effect of external sodium and calcium on calcium efflux in frog striated muscle. J Membr Biol 1978;41:1 14. 17. Apell HJ. Structure-function relationship in P-type ATPases a biophysical approach. Rev Physiol Biochem Pharmacol 2003;150:1 35. 18. Carafoli E. The Ca21 pump of the plasma membrane. J Biol Chem 1992;267:2115 8. 19. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 2001;81:21 50. 20. Bilmen JG, Khan SZ, Javed MH, Michelangeli F. Inhibition of the SERCA Ca21 pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 2001;268:6318 27. 21. Niggli V, Sigel E, Carafoli E. The purified Ca21 pump of human erythrocyte membranes catalyzes an electroneutral Ca21-H1 exchange in reconstituted liposomal systems. J Biol Chem 1982;257:2350 6. 22. Hao L, Rigaud JL, Inesi G. Ca21/H1 countertransport and electrogenicity in proteoliposomes containing erythrocyte plasma membrane Ca-ATPase and exogenous lipids. J Biol Chem 1994;269:14268 75. 23. Thomas RC. The plasma membrane calcium ATPase (PMCA) of neurones is electroneutral and exchanges 2 H1 for each Ca21 or Ba21 ion extruded. J Physiol 2009;587:315 27. 24. Inesi G, Prasad AM, Pilankatta R. The Ca21 ATPase of cardiac sarcoplasmic reticulum: physiological role and relevance to diseases. Biochem Biophys Res Commun 2008;369:182 7.

808

25. Franzini-Armstrong C. Structure of sarcoplasmic reticulum. Fed Proc 1980;39:2403 9. 26. Martonosi AN, Dux L, Terjung RL, Roufa D. Regulation of membrane assembly during development of sarcoplasmic reticulum: the possible role of calcium. Ann NY Acad Sci 1982;402:485 514. 27. MacLennan DH, Reithmeier RAF. In: Martonosi A, editor. Membranes and transport, vol. 1. New York: Plenum Press;1982. p. 567 71. 28. Martonosi A, Beeler TJ. In: Peachey LD, Adrian RH, editors. Handbook of physiology: skeletal muscle, vol. 1. Bethesda, MD: American Physiological Society;1983. p. 417 85. 29. Brody IA. Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. N Engl J Med 1969;281:187 92. 30. Odermatt A, Taschner PE, Khanna VK, Busch HF, Karpati G, Jablecki CK, et al. Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca21 ATPase, are associated with Brody disease. Nat Genet 1996;14:191 4. 31. Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, et al. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest. 2011;121:1044 52. 32. Caputo C, Gimenez M. Effects of external calcium deprivation on single muscle fibers. J Gen Physiol 1967;50:2177 95. 33. Luttgau HC, Oetliker H. The action of caffeine on the activation of the contractile mechanism in straited muscle fibres. J Physiol 1968;194:51 74. 34. Dirksen RT. Checking your SOCCs and feet: the molecular mechanisms of Ca21 entry in skeletal muscle. J Physiol 2009;587:3139 47. 35. Kurebayashi N, Ogawa Y. Depletion of Ca21 in the sarcoplasmic reticulum stimulates Ca21 entry into mouse skeletal muscle fibres. J Physiol 2001;533:185 99. 36. Lyfenko AD, Dirksen RT. Differential dependence of store-operated and excitation-coupled Ca21 entry in skeletal muscle on STIM1 and Orai1. J Physiol 2008;586:4815 24. 37. Cherednichenko G, Hurne AM, Fessenden JD, Lee EH, Allen PD, Beam KG, et al. Conformational activation of Ca21 entry by depolarization of skeletal myotubes. Proc Natl Acad Sci USA 2004;101:15793 8. 38. Putney Jr JW. A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1 12. 39. Putney Jr JW. New molecular players in capacitative Ca21 entry. J Cell Sci 2007;120:1959 65. 40. Cherednichenko G, Ward CW, Feng W, Cabrales E, Michaelson L, Samso M, et al. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol 2008;73:1203 12. 41. Bannister RA, Grabner M, Beam KG. The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor. J Biol Chem 2008;283:23217 23. 42. Bannister RA, Pessah IN, Beam KG. The skeletal L-type Ca(21) current is a major contributor to excitation-coupled Ca(21) entry. J Gen Physiol 2009;133:79 91. 43. Hurne AM, O’Brien JJ, Wingrove D, Cherednichenko G, Allen PD, Beam KG, et al. Ryanodine receptor type 1 (RyR1) mutations

PART | III

44.

45.

46.

47.

48. 49.

50.

51.

52.

53.

54.

55.

56.

57.

58.

59.

Skeletal Muscle

C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion. J Biol Chem 2005;280:36994 7004. Treves S, Vukcevic M, Jeannet PY, Levano S, Girard T, Urwyler A, et al. Enhanced excitation-coupled Ca(21) entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease. Hum Mol Genet 2011;20:589 600. Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, et al. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology 2006;105:1164 75. Gach MP, Cherednichenko G, Haarmann C, Lopez JR, Beam KG, Pessah IN, et al. Alpha2delta1 dihydropyridine receptor subunit is a critical element for excitation-coupled calcium entry but not for formation of tetrads in skeletal myotubes. Biophys J 2008; 94:3023 34. Smyth JT, Hwang SY, Tomita T, DeHaven WI, Mercer JC, Putney JW. Activation and regulation of store-operated calcium entry. J Cell Mol Med 2010;14:2337 49. Parekh AB, Putney Jr JW. Store-operated calcium channels. Physiol Rev 2005;85:757 810. Gonzalez Narvaez AA, Castillo A. Ca21 store determines gating of store operated calcium entry in mammalian skeletal muscle. J Muscle Res Cell Motil 2007;28:105 13. Launikonis BS, Barnes M, Stephenson DG. Identification of the coupling between skeletal muscle store-operated Ca21 entry and the inositol trisphosphate receptor. Proc Natl Acad Sci USA 2003;100:2941 4. Launikonis BS, Rios E. Store-operated Ca21 entry during intracellular Ca21 release in mammalian skeletal muscle. J Physiol 2007;583:81 97. Launikonis BS, Murphy RM, Edwards JN. Toward the roles of store-operated Ca21 entry in skeletal muscle. Pflugers Arch 2010;460:813 23. Kiselyov KI, Shin DM, Wang Y, Pessah IN, Allen PD, Muallem S. Gating of store-operated channels by conformational coupling to ryanodine receptors. Mol Cell 2000;6:421 31. Pan Z, Yang D, Nagaraj RY, Nosek TA, Nishi M, Takeshima H, et al. Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nat Cell Biol 2002;4:379 83. Lee EH, Cherednichenko G, Pessah IN, Allen PD. Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J Biol Chem 2006;281:10042 8. Sampieri A, Diaz-Munoz M, Antaramian A, Vaca L. The foot structure from the type 1 ryanodine receptor is required for functional coupling to store-operated channels. J Biol Chem 2005;280:24804 15. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006;441:179 85. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, KoblanHuberson M, et al. CRACM1 is a plasma membrane protein essential for store-operated Ca21 entry. Science 2006; 312:1220 3. Kruger J, Kunert-Keil C, Bisping F, Brinkmeier H. Transient receptor potential cation channels in normal and dystrophic mdx muscle. Neuromuscul Disord 2008;18:501 13.

Chapter | 56

Control of Resting Ca21 Concentration in Skeletal Muscle

60. Kunert-Keil C, Bisping F, Kruger J, Brinkmeier H. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics 2006;7:159. 61. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 2002;158:1089 96. 62. Ramsey IS, Delling M, Clapham DE. An introduction to TRP channels. Annu Rev Physiol 2006;68:619 47. 63. Sabourin J, Lamiche C, Vandebrouck A, Magaud C, Rivet J, Cognard C, et al. Regulation of TRPC1 and TRPC4 cation channels requires an alpha1-syntrophin-dependent complex in skeletal mouse myotubes. J Biol Chem 2009;284:36248 61. 64. Rosenberg P, Hawkins A, Stiber J, Shelton JM, Hutcheson K, Bassel-Duby R, et al. TRPC3 channels confer cellular memory of recent neuromuscular activity. Proc Natl Acad Sci USA 2004;101:9387 92. 65. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 2007;76:387 417. 66. Pessah IN, Molinski TF, Meloy TD, Wong P, Buck ED, Allen PD, et al. Bastadins relate ryanodine-sensitive and -insensitive Ca21 efflux pathways in skeletal SR and BC3H1 cells. Am J Physiol 1997;272:C601 14. 67. Mack MM, Molinski TF, Buck ED, Pessah IN. Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta. Role of FKBP12 in channel gating. J Biol Chem 1994;269:23236 49. 68. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG, Allen PD. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 1996;380:72 5. 69. Franzini-Armstrong C, Kish JW. Alternate disposition of tetrads in peripheral couplings of skeletal muscle. J Muscle Res Cell Motil 1995;16:319 24. 70. Takekura H, Bennett L, Tanabe T, Beam KG, Franzini-Armstrong C. Restoration of junctional tetrads in dysgenic myotubes by dihydropyridine receptor cDNA. Biophys J 1994;67:793 803. 71. Protasi F, Franzini-Armstrong C, Allen PD. Role of ryanodine receptors in the assembly of calcium release units in skeletal muscle. J Cell Biol 1998;140:831 42. 72. Eltit JM, Li H, Ward CW, Molinski TF, Pessah IN, Allen PD, et al. An orthograde DHPR signal regulates RyR1 passive leak. Proc Natl Acad Sci USA 2011;108:7046 51. 73. Allen DG, Blinks JR, Prendergast FG. Aequorin luminescence: relation of light emission to calcium concentration a calciumindependent component. Science 1977;195:996 8. 74. Blinks JR, Wier WG, Hess P, Prendergast FG. Measurement of Ca21 concentrations in living cells. Prog Biophys Mol Biol 1982;40:1 114. 75. Blatter LA, Blinks JR. Simultaneous measurement of Ca21 in muscle with Ca electrodes and aequorin. Diffusible cytoplasmic constituent reduces Ca(21)-independent luminescence of aequorin. J Gen Physiol 1991;98:1141 60. 76. Blinks JR, Moore ED. Practical aspects of the use of photoproteins as biological calcium indicators. Soc Gen Physiol Ser 1986;40:229 38. 77. Baylor SM, Chandler WK, Marshall MW. Dichroic components of Arsenazo III and dichlorophosphonazo III signals in skeletal muscle fibres. J Physiol 1982;331:179 210.

809

78. Baylor SM, Chandler WK, Marshall MW. Use of metallochromic dyes to measure changes in myoplasmic calcium during activity in frog skeletal muscle fibres. J Physiol 1982;331:139 77. 79. Baylor SM, Hollingworth S, Hui CS, Quinta-Ferreira ME. Properties of the metallochromic dyes Arsenazo III, Antipyrylazo III and Azo1 in frog skeletal muscle fibres at rest. J Physiol 1986;377:89 141. 80. Baylor SM, Quinta-Ferreira ME, Hui CS. Comparison of isotropic calcium signals from intact frog muscle fibers injected with Arsenazo III or Antipyrylazo III. Biophys J 1983;44:107 12. 81. Beeler TJ, Schibeci A, Martonosi A. The binding of arsenazo III to cell components. Biochim Biophys Acta 1980;629:317 27. 82. Beeler T. Oxidation of sulfhydryl groups and inhibition of the (Ca21 1 Mg21)-ATPase by arsenazo III. Biochim Biophys Acta 1990;1027:264 7. 83. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca21 indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440 50. 84. Rink TJ, Pozzan T. Using quin2 in cell suspensions. Cell Calcium 1985;6:133 44. 85. Tsien RY, Rink TJ. Neutral carrier ion-selective microelectrodes for measurement of intracellular free calcium. Biochim Biophys Acta 1980;599:623 38. 86. Avila G, Dirksen RT. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. J Gen Physiol 2001;118:277 90. 87. Avila G, O’Brien JJ, Dirksen RT. Excitation contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc Natl Acad Sci USA 2001;98:4215 20. 88. Dainese M, Quarta M, Lyfenko AD, Paolini C, Canato M, Reggiani C, et al. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J 2009;23:1710 20. 89. Ducreux S, Zorzato F, Ferreiro A, Jungbluth H, Muntoni F, Monnier N, et al. Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes. Biochem J 2006; 395:259 66. 90. Iaizzo PA, Klein W, Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Arch 1988;411:648 53. 91. Iaizzo PA, Seewald M, Oakes SG, Lehmann-Horn F. The use of Fura-2 to estimate myoplasmic [Ca21] in human skeletal muscle. Cell Calcium 1989;10:151 8. 92. DeFeo TT, Morgan KG. A comparison of two different indicators: quin 2 and aequorin in isolated single cells and intact strips of ferret portal vein. Pflugers Arch 1986;406:427 9. 93. Spurgeon HA, Stern MD, Baartz G, Raffaeli S, Hansford RG, Talo A, et al. Simultaneous measurement of Ca21, contraction, and potential in cardiac myocytes. Am J Physiol 1990;258: H574 86. 94. Williams DA, Fogarty KE, Tsien RY, Fay FS. Calcium gradients in single smooth muscle cells revealed by the digital imaging microscope using Fura-2. Nature 1985;318:558 61. 95. Murphy E, Jacob R, Lieberman M. Cytosolic free calcium in chick heart cells. Its role in cell injury. J Mol Cell Cardiol 1985;17:221 31.

810

96. Tsien R, Pozzan T. Measurement of cytosolic free Ca21 with quin2. Methods Enzymol 1989;172:230 62. 97. Becker PL, Fay FS. Photobleaching of fura-2 and its effect on determination of calcium concentrations. Am J Physiol 1987;253: C613 8. 98. David-Dufilho M, Montenay-Garestier T, Devynck MA. Fluorescence measurements of free Ca21 concentration in human erythrocytes using the Ca21-indicator fura-2. Cell Calcium 1988;9:167 79. 99. Malgaroli A, Milani D, Meldolesi J, Pozzan T. Fura-2 measurement of cytosolic free Ca21 in monolayers and suspensions of various types of animal cells. J Cell Biol 1987;105: 2145 55. 100. Kurebayashi N, Harkins AB, Baylor SM. Use of fura red as an intracellular calcium indicator in frog skeletal muscle fibers. Biophys J 1993;64:1934 60. 101. Alvarez-Leefmans FJ, Gamino SM, Giraldez F, GonzalezSerratos H. Intracellular free magnesium in frog skeletal muscle fibres measured with ion-selective micro-electrodes. J Physiol 1986;378:461 83.

PART | III

Skeletal Muscle

102. Tsien RY, Rink TJ. Ca21-selective electrodes: a novel PVCgelled neutral carrier mixture compared with other currently available sensors. J Neurosci Methods 1981;4:73 86. 103. Oehme M, Kessler M, Simon W. Neutral carrier Ca21 microelectrodes. Chimia 1976;30:204 6. 104. Schefer U, Ammann D. Neutral carrier based Ca21 selective electrode with detection limit in the subnanomolar range. Anal Chem 1986;58:2282. 105. Lopez JR, Linares N, Pessah IN, Allen PD. Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca21]i. Am J Physiol Cell Physiol 2005;288:C606 12. 106. Lopez JR, Rojas B, Gonzalez MA, Terzic A. Myoplasmic Ca21 concentration during exertional rhabdomyolysis. Lancet 1995;345:424 5. 107. Westerblad H, Lee JA, Lamb AG, Bolsover SR, Allen DG. Spatial gradients of intracellular calcium in skeletal muscle during fatigue. Pflugers Arch 1990;415:734 40. 108. Rios E. RyR1 expression and the cell boundary theorem. J Biol Chem 2010;285:le13 [author reply le14].